Related Experiment Videos

Aspergillus nidulans infection in chronic granulomatous disease

B H Segal1, E S DeCarlo, K J Kwon-Chung

  • 1Laboratory of Host Defenses, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892-1886, USA.

Medicine
|October 17, 1998
PubMed

Insights

Chronic granulomatous disease (CGD) patients face severe infections from Aspergillus species. Aspergillus nidulans, though rare, is a more virulent pathogen than Aspergillus fumigatus in CGD, often leading to poorer outcomes.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Mycology

Background:

  • Chronic granulomatous disease (CGD) is a primary immunodeficiency characterized by defective phagocyte NADPH oxidase function.
  • This defect leads to recurrent, severe bacterial and fungal infections, with Aspergillus species being common culprits.

Observation:

  • This study reviewed cases of Aspergillus nidulans isolation at the National Institutes of Health between 1976 and 1997.
  • Aspergillus nidulans was identified as a pathogen exclusively in patients with CGD, unlike other patient groups.

Findings:

  • Aspergillus nidulans infections in CGD patients were associated with higher mortality, increased bone involvement, and disseminated disease compared to Aspergillus fumigatus.
  • Patients with A. nidulans infections required longer amphotericin B treatment and more frequent surgical interventions.

Implications:

  • Aspergillus nidulans represents a distinct and particularly virulent pathogen in the context of CGD.
  • The general refractoriness of A. nidulans to antifungal therapy suggests that early surgical intervention may be crucial for patient management.

Related Concept Videos